STAT
DECEMBER 3, 2024
Swedish pharmaceutical company Orexo will no longer pursue an app for treating depression after many years of struggling to sell it. Orexo announced this week that it will no longer license the product, called Deprexis, from German manufacturer GAIA.
STAT
MARCH 17, 2025
In a brief statement , the Belgian Competition Authority alleged that Roche offered financial incentives to hospitals between 2017 and 2020 to deter them from considering competitive bids from other pharmaceutical companies that could supply similar medicines.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
NOVEMBER 2, 2020
Ahead of Frontiers Health 2020, steering committee members Roberto Ascione and Paul Tunnah from Healthware give us their thoughts on the trends driving the bright future of digital health. The post Deep Dive: Digital Health Innovation 2020 appeared first on. The key elements driving the success of digital health.
pharmaphorum
SEPTEMBER 17, 2020
Patient simulations have been a key tool for educating physicians for decades – and now cutting-edge tech is helping them become more impactful than ever. • Read the latest issue Deep Dive: Communications 2020 in full. The post Deep Dive: Communications 2020 appeared first on. Subscribe to future issues of Deep Dive.
STAT
NOVEMBER 15, 2023
The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10.
STAT
MAY 11, 2023
Thanks to changes in tax law six years ago, several of the largest pharmaceutical companies saw their tax rates fall substantially, but they also reported that most of their profits were shifted offshore in an effort to avoid paying U.S. in 2020, down from 19.6% in 2020, down from 19.6% Senate Committee.
Pharma Marketing Network
JULY 19, 2023
But in order to be truly effective, sponsorships must be aligned with a company’s brand values. For pharmaceutical companies, this means aligning sponsorships with causes that are related to health and wellness. In 2020, the company committed to investing $5 billion in research and development over the next five years.
Expert insights. Personalized for you.
120 
Let's personalize your content